Acrivon Therapeutics, Inc. Quarterly Operating Lease, Liability in USD from Q4 2021 to Q3 2024

Taxonomy & unit: us-gaap: USD
Description: Present value of lessee's discounted obligation for lease payments from operating lease.
Summary: Acrivon Therapeutics, Inc. quarterly Operating Lease, Liability history and growth rate from Q4 2021 to Q3 2024.
Acrivon Therapeutics, Inc. Operating Lease, Liability for the quarter ending September 30, 2024 was $4.01M, a 9.21% decline year-over-year.

Operating Lease, Liability, Quarterly (USD)

Operating Lease, Liability, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q3 2024	$4.01M	-$407K	-9.21%	Sep 30, 2024	10-Q	2024-11-13
Q2 2024	$4.22M	-$380K	-8.26%	Jun 30, 2024	10-Q	2024-08-13
Q1 2024	$4.45M	-$341K	-7.13%	Mar 31, 2024	10-Q	2024-05-14
Q4 2023	$4.64M	-$317K	-6.39%	Dec 31, 2023	10-Q	2024-11-13
Q3 2023	$4.42M	-$717K	-14%	Sep 30, 2023	10-Q	2023-11-09
Q2 2023	$4.6M			Jun 30, 2023	10-Q	2023-08-11
Q1 2023	$4.79M			Mar 31, 2023	10-Q	2023-05-09
Q4 2022	$4.96M	-$667K	-11.9%	Dec 31, 2022	10-K	2024-03-28
Q3 2022	$5.14M			Sep 30, 2022	10-Q	2022-12-15
Q4 2021	$5.63M			Dec 31, 2021	10-K	2023-03-28

* An asterisk sign (*) next to the value indicates that the value is likely invalid.